nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer
|
Gibson, Angelia D. |
|
2002 |
4 |
1 |
p. 23-25 3 p. |
artikel |
2 |
Chemotherapy in Advanced non—small-Cell Lung Cancer: A Look Behind and Ahead
|
Selvaggi, Giovanni |
|
2002 |
4 |
1 |
p. 26-34 9 p. |
artikel |
3 |
Farnesyltransferase Inhibitors: A Promising Future in Cancer Treatment
|
Khuri, Fadlo R. |
|
2002 |
4 |
1 |
p. 63-64 2 p. |
artikel |
4 |
Highlights From: 38th Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida May 18–21, 2002
|
DeGrendele, Heather |
|
2002 |
4 |
1 |
p. 16-20 5 p. |
artikel |
5 |
Hypersensitivity Pneumonitis in Advanced Non-Small-Cell Lung Cancer Patients Receiving Gemcitabine and Paclitaxel: Report of Two Cases and a Review of the Literature
|
Kudrik, Fred J. |
|
2002 |
4 |
1 |
p. 52-56 5 p. |
artikel |
6 |
The Possible Use of Uniform PORT Doses Is Important in the SEER Analysis, but Undetected Selection Bias Remains an Issue
|
Bonner, James A. |
|
2002 |
4 |
1 |
p. 45-46 2 p. |
artikel |
7 |
The Role of Farnesyltransferase Inhibitors in Lung Cancer Therapy
|
Dy, Grace K. |
|
2002 |
4 |
1 |
p. 57-62 6 p. |
artikel |
8 |
Unfavorable Therapeutic Index of Cisplatin/Gemcitabine/Vinorelbine in Advanced non—small-Cell Lung Cancer
|
Hesketh, Paul J. |
|
2002 |
4 |
1 |
p. 47-51 5 p. |
artikel |
9 |
Use of Postoperative Radiotherapy for Node-Positive non—small-Cell Lung Cancer
|
Rescigno, John |
|
2002 |
4 |
1 |
p. 35-44 10 p. |
artikel |